One lot of thyroid tablets was pulled nationwide after tests showed the pills could be too strong.
Story Snapshot
- Vitruvias recalled one lot of 30 mg thyroid tablets at the consumer level
- Testing confirmed potential “superpotency,” which can cause hyperthyroidism symptoms
- Lot 504950, NDC 69680-166-00, with expiry 9/30/2026, is the affected batch
- 3,655 units released, 1,955 sold, shipped nationwide in 2025; no injuries reported to date
What Was Recalled, Where It Went, And Why It Matters
Vitruvias Therapeutics issued a voluntary recall of one lot of Thyroid Tablets, United States Pharmacopeia 30 milligrams, after testing showed the product could be superpotent. The affected lot is 504950, labeled with National Drug Code 69680-166-00, and expires September 30, 2026.
The company released 3,655 units and sold 1,955 units. Shipments went to direct accounts across the United States between January 31, 2025, and September 30, 2025.
Superpotent thyroid hormone can push the body too far, too fast. The Food and Drug Administration warned that extra hormone can cause hyperthyroidism symptoms. These include weight loss, heat intolerance, fatigue, nervousness, muscle weakness, and high blood pressure.
Heart risks include chest pain, rapid heart rate, and rhythm problems, which matter most for older adults and people with heart disease. Vitruvias reported no adverse events linked to this recall as of the notice date.
'Superpotent' Thyroid medication recalled one month after FDA advises against similar tablets https://t.co/jGK75IOEcX pic.twitter.com/jhFrWTCro8
— New York Post (@nypost) August 25, 2026
How Superpotency Shows Up In Real Life
Patients do not need a lab to sense a dose that runs hot. A person stable on thyroid therapy who starts to feel jittery, sweaty, or short of breath should pause and call their doctor. A fast or irregular heartbeat is a red flag, especially if there is chest pain.
Doctors often check thyroid stimulating hormone and free hormone levels when symptoms shift. If the bottle lists lot 504950, stop using it and follow recall instructions.
Pharmacies and clinics should pull inventory now. They can match National Drug Code and lot numbers to shelf stock and records. Distributors should notify accounts and confirm returns. This is standard recall hygiene that protects patients before harm occurs.
The Food and Drug Administration’s recall listings show potency errors remain a steady slice of drug recalls over time, so tight execution matters every time.
Why Thyroid Pills Are Repeat Recall Targets
Thyroid drugs live in a narrow window. A little low leaves people slow and foggy. A little high leaves people wired and worn out. That thin gap turns small production shifts into big clinical swings.
Prior recalls in this class have cited both superpotency and subpotency, and some named percentages as high as one hundred fifteen percent of label claim in other brands. This history explains why pharmacies and doctors take even a single-lot alert seriously.
Recall: Vitruvias Thyroid Tablets USP 30 mg — lot 504950, exp. 9/30/2026, NDC 69680-166-00 — for potential superpotency.
Check your bottle. If it matches, contact your pharmacy or clinician. Do not discontinue without clinician guidance.https://t.co/rRHBYf0Ump
— The Modern Bio (@themodernbio) August 26, 2026
Patients should check their bottles, contact their pharmacy or doctor if they have the lot, and report symptoms if they feel off. This is how a safety net prevents harm without stoking panic.
What Patients And Caregivers Should Do Now
Check the label for Thyroid Tablets, United States Pharmacopeia 30 milligrams, National Drug Code 69680-166-00, and lot number 504950. If it matches, stop using the product and follow return or replacement steps from your pharmacy or the company.
Keep a short symptom log if you felt any racing heart, tremor, or heat intolerance. Share that with your doctor. If symptoms are severe, seek urgent care. If your bottle lists a different lot, this recall does not apply to you.
Sources:
nypost.com, fda.gov, usatoday.com, passionhealthphysicians.com
